8:19cv919 • April 17, 2019
Class Period Start
December 21, 2018
Class Period End
June 28, 2019
PSLRA Deadline
June 17, 2019
Case Allegations
10b5
Statutes of Repose
Dec 21, 2021
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
December 16, 2020
Settlement Fund
$3,000,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased or otherwise acquired Apyx Medical Corporation common stock (“Apyx Common Stock”) or call options on Apyx Common Stock (“Apyx Call Options”), or sold put options on Apyx Common Stock (“Apyx Put Options”) during the period between December 21, 2018 and April 1, 2019, inclusive.
Claim Administrator
Strategic Claims Services
Pritchard v. Apyx Medical Corp., et al.
c/o Strategic Claims Services
P.O. Box 230
600 N. Jackson St., Suite 205 Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
-Hearing Date
November 6, 2020
Opt-out Deadline
October 16, 2020
Settlement Note
Download hereProof Of Claim
Download here
Jun 15, 2021
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Nov 6, 2020
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Oct 20, 2020
Jul 21, 2020
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Jul 21, 2020
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Mar 11, 2020
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
Oct 3, 2019
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Sep 3, 2019
A new complaint has been filed on behalf of certain investors in Apyx Medical Corp. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Aug 2, 2019
Jul 16, 2019
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Apr 17, 2019
A securities fraud class action complaint has been filed on behalf of certain investors in Apyx Medical Corp.
TOP
